Skip to main content
An official website of the United States government

Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Muzumdar, Mandar Deepak

Yale University
United States

Targeting pancreatic endocrine-exocrine signaling in cancer development with incretin mimetics 5R01CA296916-02 Anda Vlad, M.D., Ph.D.
Mwesigwa, Betty

Makerere University Walter Reed Project
United States

Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA) 5UG1CA275412-04 Maria Silvina Frech, Ph.D., M.S.
Nabavi, Sheida

University Of Connecticut Storrs
United States

SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening 5R01CA297855-02 Claire Zhu, Ph.D.
Naicker, Nivashnee

Centre/Aids Programme/Res/South Africa
United States

CAPRISA CASCADE Clinical Trials Network Clinical Research Site 5UG1CA284671-03 Maria Silvina Frech, Ph.D., M.S.
Neslund-Dudas, Christine Marie

Henry Ford Health + Michigan State University Health Sciences
United States

HFH-MSU CSRN ACCrual Enrollment and Screening Site 5UG1CA287007-03 Elyse LeeVan, M.D., M.P.H.
Nicolson, Fay

Dana-Farber Cancer Inst
United States

SESORRS endoscopy for the staging and evaluation of colorectal cancer 5R00CA266921-05 Gary Della'Zanna, D.O., M.Sc.
Nyamathi, Adeline M

University Of California-Irvine
United States

Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India 3R01CA285063-03S2 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Oberg, Ann Laura

Mayo Clinic Rochester
United States

Management and Data Coordination Unit for PCDC 5U24CA274496-04 Guillermo Marquez, Ph.D.
Olopade, Olufunmilayo F.

University Of Chicago
United States

The Funding Mechanism of the Pilot Trial 5R01CA276652-03 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ondrey, Frank G.

University Of Minnesota
United States

Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia 5R01CA254270-04 PAR-21-035 (R01 Clinical Trial Required)